Last 1,090 GBp
Change Today +3.00 / 0.28%
Volume 4.4M
SN/ On Other Exchanges
New York
As of 11:35 AM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

smith & nephew plc (SN/) Snapshot

1,091 GBp
Previous Close
1,087 GBp
Day High
1,095 GBp
Day Low
1,073 GBp
52 Week High
06/5/14 - 1,136 GBp
52 Week Low
11/27/13 - 806.00 GBp
Market Cap
Average Volume 10 Days
0.56 GBp
Shares Outstanding
0.30 GBp
Dividend Yield
Current Stock Chart for SMITH & NEPHEW PLC (SN/)

Related News

No related news articles were found.

smith & nephew plc (SN/) Related Businessweek News

No Related Businessweek News Found

smith & nephew plc (SN/) Details

Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The company’s Advanced Surgical Devices segment offers orthopaedic reconstruction implants for hip, knee, and shoulder joints; and ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. It also provides sports medicine products, which offer surgeons an array of instruments, technologies, and implants to perform minimally invasive surgery of the joints, including knee, hip, and shoulder repair; and trauma and extremities products consisting of internal and external devices and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures. In addition, this segment provides arthroscopy enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, as well as offers radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissues to healthcare providers. The company’s Advanced Wound Management segment offers a range of initial wound bed preparation and full wound closure products. Its products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, such as burns and invasive surgery. Smith & Nephew plc primarily serves medical and surgical treatments and service providers. The company was founded in 1856 and is headquartered in London, the United Kingdom.

14,000 Employees
Last Reported Date: 10/30/14
Founded in 1856

smith & nephew plc (SN/) Top Compensated Officers

Chief Executive Officer, Director, Chairman o...
Total Annual Compensation: $4.2M
Chief Financial Officer, Director and Member ...
Total Annual Compensation: $2.0M
Compensation as of Fiscal Year 2013.

smith & nephew plc (SN/) Key Developments

Smith & Nephew Signs $800 Million Private Placement

Smith & Nephew announced that it has signed a private placement agreement to borrow $800 million of long-term debt, comprising $730 million of fixed rate debt and $70 million of floating rate debt. The fixed debt has an average rate of 3.1% and an average maturity of just over eight years. The funds will be used to repay existing bank debt.

Smith & Nephew To Reportedly Sell Wound Care Business

Smith & Nephew plc (LSE:SN.) could be looking to sell its wound care business for £2.6 billion, MailOnline reported.

Stryker Rumored To Acquire Smith & Nephew

Stryker Corporation (NYSE:SYK) is rumored to make a cash bid to acquire Smith & Nephew plc (LSE:SN.) for £13 billion plus or near £15 a share, when Takeover Panel approves the bid at the end of November, MailOnline reported. Shares in Smith & Nephew rallied from £10.69 to £10.87.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SN/:LN 1,090.00 GBp +3.00

SN/ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Coloplast A/S kr513.00 DKK +2.00
CR Bard Inc $166.50 USD -0.61
Edwards Lifesciences Corp $123.50 USD -1.89
Olympus Corp ¥4,210 JPY +20.00
St Jude Medical Inc $66.80 USD +2.53
View Industry Companies

Industry Analysis


Industry Average

Valuation SN/ Industry Range
Price/Earnings 30.5x
Price/Sales 3.4x
Price/Book 3.8x
Price/Cash Flow 30.3x
TEV/Sales 3.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SMITH & NEPHEW PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at